Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Tocilizumab might be an effective treatment for COVID-19.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib might be used to treat hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

RTA 408 cream protects mice from radiation skin damage.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib taken by mouth helps treat hair loss in children.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

A new compound shows promise as a topical treatment for hair loss.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Enhancing Tregs can protect against alopecia areata.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Entospletinib effectively prevents eye and skin GVHD in mice.

Tofacitinib helped a woman regrow hair with no major side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

The combination therapy was effective and well-tolerated, especially in young patients.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.